No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients

Seung Gul Kang; Jung Eun Choi; Hyonggin An; Se Won Lim; Heon Jeong Lee; Changsu Han; Yong Ku Kim; Seung Hyun Kim; Sung Nam Cho; Min Soo Lee; Sook Haeng Joe; In Kwa Jung; Leen Kim

doi:10.1016/j.pnpbp.2008.05.016

No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients

Seung Gul Kang, Jung Eun Choi, Hyonggin An, Se Won Lim, Heon Jeong Lee, Changsu Han, Yong Ku Kim, Seung Hyun Kim, Sung Nam Cho, Min Soo Lee, Sook Haeng Joe, In Kwa Jung, Leen Kim

Department of Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

20 Citations (Scopus)

Abstract

Objective: This study investigated whether the brain-derived neurotrophic factor (BDNF) gene Val66Met single-nucleotide polymorphism (SNP) is associated with antipsychotic-induced tardive dyskinesia (TD) in schizophrenia. Methods: Genotyping was performed for the BDNF gene Val66Met SNP in Korean schizophrenic patients with (n = 83) and without TD (n = 126) who were matched for antipsychotic drug exposure and other relevant variables. Results: The frequencies of genotypes (χ² = 2.37, p = 0.306) and alleles (χ² = 0.03, p = 0.867) did not differ significantly between these two groups. Conclusion: These findings suggest that the BDNF polymorphism does not play a major role in the susceptibility to TD in schizophrenic patients. Crown

Original language	English
Pages (from-to)	1545-1548
Number of pages	4
Journal	Progress in Neuro-Psychopharmacology and Biological Psychiatry
Volume	32
Issue number	6
DOIs	https://doi.org/10.1016/j.pnpbp.2008.05.016
Publication status	Published - 2008 Aug 1

Keywords

Brain-derived neurotrophic factor
Polymorphism
Schizophrenia
Tardive dyskinesia

ASJC Scopus subject areas

Pharmacology
Biological Psychiatry

Access to Document

10.1016/j.pnpbp.2008.05.016

Cite this

Kang, S. G., Choi, J. E., An, H., Lim, S. W., Lee, H. J., Han, C., Kim, Y. K., Kim, S. H., Cho, S. N., Lee, M. S., Joe, S. H., Jung, I. K., & Kim, L. (2008). No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(6), 1545-1548. https://doi.org/10.1016/j.pnpbp.2008.05.016

No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients. / Kang, Seung Gul; Choi, Jung Eun; An, Hyonggin et al.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 32, No. 6, 01.08.2008, p. 1545-1548.

Research output: Contribution to journal › Article › peer-review

Kang, SG, Choi, JE, An, H, Lim, SW, Lee, HJ, Han, C, Kim, YK, Kim, SH, Cho, SN, Lee, MS, Joe, SH, Jung, IK & Kim, L 2008, 'No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients', Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 6, pp. 1545-1548. https://doi.org/10.1016/j.pnpbp.2008.05.016

@article{92043eb79d7e4e65acf4de2ed3e245d0,

title = "No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients",

abstract = "Objective: This study investigated whether the brain-derived neurotrophic factor (BDNF) gene Val66Met single-nucleotide polymorphism (SNP) is associated with antipsychotic-induced tardive dyskinesia (TD) in schizophrenia. Methods: Genotyping was performed for the BDNF gene Val66Met SNP in Korean schizophrenic patients with (n = 83) and without TD (n = 126) who were matched for antipsychotic drug exposure and other relevant variables. Results: The frequencies of genotypes (χ2 = 2.37, p = 0.306) and alleles (χ2 = 0.03, p = 0.867) did not differ significantly between these two groups. Conclusion: These findings suggest that the BDNF polymorphism does not play a major role in the susceptibility to TD in schizophrenic patients. Crown",

keywords = "Brain-derived neurotrophic factor, Polymorphism, Schizophrenia, Tardive dyskinesia",

author = "Kang, {Seung Gul} and Choi, {Jung Eun} and Hyonggin An and Lim, {Se Won} and Lee, {Heon Jeong} and Changsu Han and Kim, {Yong Ku} and Kim, {Seung Hyun} and Cho, {Sung Nam} and Lee, {Min Soo} and Joe, {Sook Haeng} and Jung, {In Kwa} and Leen Kim",

year = "2008",

month = aug,

day = "1",

doi = "10.1016/j.pnpbp.2008.05.016",

language = "English",

volume = "32",

pages = "1545--1548",

journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",

issn = "0278-5846",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients

AU - Kang, Seung Gul

AU - Choi, Jung Eun

AU - An, Hyonggin

AU - Lim, Se Won

AU - Lee, Heon Jeong

AU - Han, Changsu

AU - Kim, Yong Ku

AU - Kim, Seung Hyun

AU - Cho, Sung Nam

AU - Lee, Min Soo

AU - Joe, Sook Haeng

AU - Jung, In Kwa

AU - Kim, Leen

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Objective: This study investigated whether the brain-derived neurotrophic factor (BDNF) gene Val66Met single-nucleotide polymorphism (SNP) is associated with antipsychotic-induced tardive dyskinesia (TD) in schizophrenia. Methods: Genotyping was performed for the BDNF gene Val66Met SNP in Korean schizophrenic patients with (n = 83) and without TD (n = 126) who were matched for antipsychotic drug exposure and other relevant variables. Results: The frequencies of genotypes (χ2 = 2.37, p = 0.306) and alleles (χ2 = 0.03, p = 0.867) did not differ significantly between these two groups. Conclusion: These findings suggest that the BDNF polymorphism does not play a major role in the susceptibility to TD in schizophrenic patients. Crown

AB - Objective: This study investigated whether the brain-derived neurotrophic factor (BDNF) gene Val66Met single-nucleotide polymorphism (SNP) is associated with antipsychotic-induced tardive dyskinesia (TD) in schizophrenia. Methods: Genotyping was performed for the BDNF gene Val66Met SNP in Korean schizophrenic patients with (n = 83) and without TD (n = 126) who were matched for antipsychotic drug exposure and other relevant variables. Results: The frequencies of genotypes (χ2 = 2.37, p = 0.306) and alleles (χ2 = 0.03, p = 0.867) did not differ significantly between these two groups. Conclusion: These findings suggest that the BDNF polymorphism does not play a major role in the susceptibility to TD in schizophrenic patients. Crown

KW - Brain-derived neurotrophic factor

KW - Polymorphism

KW - Schizophrenia

KW - Tardive dyskinesia

UR - http://www.scopus.com/inward/record.url?scp=47749114538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47749114538&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2008.05.016

DO - 10.1016/j.pnpbp.2008.05.016

M3 - Article

C2 - 18602732

AN - SCOPUS:47749114538

SN - 0278-5846

VL - 32

SP - 1545

EP - 1548

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

IS - 6

ER -

No association between the brain-derived neurotrophic factor gene Val66Met polymorphism and tardive dyskinesia in schizophrenic patients

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this